Skip to main content
OpenTrials

Clinical trial condition

Neoplastic Processes

Explore clinical trials studying Neoplastic Processes. Study availability and eligibility vary by location and protocol.

3,267 public trials 689 recruiting studies
Refine in advanced search Browse all conditions

Neoplastic Processes trial results

Completed

PLAN Intervention to Enhance Engagement of Latino Cancer Patients in Advanced Care Planning

NCT04889144

Conditions
Behavior, Communication, Locally Advanced Malignant Solid Neoplasm, +6 more
Locations
  • Weill Cornell Medicine New York, United States
  • UT Southwestern/Simmons Cancer Center-Dallas Dallas, Texas, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
  • Confluence Health Wenatchee, Washington, United States
View Trial Details
Completed

Cemiplimab and ISA101b Vaccine in Adult Participants With Recurrent/Metastatic Human Papillomavirus (HPV)16 Cervical Cancer Who Have Experienced Disease Progression After First Line Chemotherapy

NCT04646005

Conditions
Adenocarcinoma, Carcinoma, Cervical Cancer, +21 more
Locations
  • Arizona Oncology Associates Tucson, Arizona, United States
  • Arizona Oncology Associates Tucson, Arizona, United States
  • Regeneron Research Site Orange, California, United States
  • Universitair Ziekenhuis Gent Ghent, East Flanders, Belgium
View all 26 locations
View Trial Details
Completed

A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors

NCT04853017

Conditions
Adenocarcinoma, Adnexal Diseases, Bile Duct Cancer, +57 more
Locations
  • City of Hope Duarte, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • University of Colorado Aurora, Colorado, United States
  • University of Iowa Iowa City, Iowa, United States
View Trial Details
Completed

A Study of ANV419 Alone or in Combination With Approved Treatment in Patients With Cutaneous Melanoma (OMNIA-1).

NCT05578872

Conditions
Adult Disease, Advanced Solid Tumor, Cutaneous Melanoma, +19 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of California San Diego La Jolla, California, United States
  • University of California San Francisco San Francisco, California, United States
  • University of Colorado Denver Denver, Colorado, United States
View all 25 locations
View Trial Details
Completed

A Phase 1/2, Open-Label, Dose-Escalation, Safety Study of INCAGN01949 in Subjects With Advanced or Metastatic Solid Tumors

NCT02923349

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Malignancies, +45 more
Locations
  • Rutgers, The State University of New Jersey New Brunswick, New Jersey, United States
  • New York University Clinical Cancer Center New York, United States
  • Vanderbilt University Medical Center Nashville, Tennessee, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details

Related conditions